Bodycote (LON:BOY – Get Free Report) had its price objective upped by investment analysts at Royal Bank Of Canada from GBX 750 to GBX 950 in a research report issued on Thursday, MarketBeat reports. The firm presently has a “sector perform” rating on the stock. Royal Bank Of Canada’s price target suggests a potential upside of 3.88% from the stock’s current price.
BOY has been the subject of a number of other reports. Jefferies Financial Group reiterated a “buy” rating and set a GBX 900 price target on shares of Bodycote in a report on Wednesday, July 29th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 900 target price on shares of Bodycote in a research note on Thursday. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 960 price target on shares of Bodycote in a report on Thursday. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of GBX 875.83.
Check Out Our Latest Stock Analysis on BOY
Bodycote Price Performance
Bodycote (LON:BOY – Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The company reported GBX 18.10 earnings per share for the quarter. Bodycote had a return on equity of 9.30% and a net margin of 7.87%. On average, analysts forecast that Bodycote will post 54.0540541 EPS for the current fiscal year.
About Bodycote
The leading provider of heat treatment and specialist thermal processing services worldwide.
Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process.
Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.
Further Reading
- Five stocks we like better than Bodycote
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.
